| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.00033 | 1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.00031 | 1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.00025 | 1 |